Olstein Capital Management LP Upped Its Universal Hlth Svcs (UHS) Position by $2.15 Million; As Microsoft (MSFT) Share Price Rose, Broderick Brian C Boosted by $566,950 Its Holding

April 21, 2018 - By Nellie Frank

Universal Health Services, Inc. (NYSE:UHS) Logo

Broderick Brian C increased its stake in Microsoft Corp (MSFT) by 14.1% based on its latest 2017Q4 regulatory filing with the SEC. Broderick Brian C bought 6,670 shares as the company’s stock rose 4.63% while stock markets declined. The institutional investor held 53,959 shares of the prepackaged software company at the end of 2017Q4, valued at $4.62 million, up from 47,289 at the end of the previous reported quarter. Broderick Brian C who had been investing in Microsoft Corp for a number of months, seems to be bullish on the $731.48B market cap company. The stock decreased 1.15% or $1.11 during the last trading session, reaching $95. About 25.59 million shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 37.43% since April 21, 2017 and is uptrending. It has outperformed by 25.88% the S&P500.

Olstein Capital Management Lp increased its stake in Universal Hlth Svcs Inc (UHS) by 33.93% based on its latest 2017Q4 regulatory filing with the SEC. Olstein Capital Management Lp bought 19,000 shares as the company’s stock rose 4.68% while stock markets declined. The institutional investor held 75,000 shares of the health care company at the end of 2017Q4, valued at $8.50M, up from 56,000 at the end of the previous reported quarter. Olstein Capital Management Lp who had been investing in Universal Hlth Svcs Inc for a number of months, seems to be bullish on the $11.34 billion market cap company. The stock decreased 0.81% or $0.99 during the last trading session, reaching $120.52. About 657,714 shares traded. Universal Health Services, Inc. (NYSE:UHS) has declined 4.39% since April 21, 2017 and is downtrending. It has underperformed by 15.94% the S&P500.

Investors sentiment decreased to 0.77 in 2017 Q4. Its down 0.06, from 0.83 in 2017Q3. It dropped, as 39 investors sold MSFT shares while 1012 reduced holdings. 134 funds opened positions while 676 raised stakes. 5.46 billion shares or 0.90% less from 5.51 billion shares in 2017Q3 were reported. Investment House Ltd Liability owns 332,067 shares. National Bank Of Montreal Can reported 16.36 million shares. Lawson Kroeker Inc Ne, Nebraska-based fund reported 133,446 shares. Indiana Trust Investment reported 0.8% in Microsoft Corporation (NASDAQ:MSFT). Banque Pictet And Cie Sa holds 549,042 shares or 0.94% of its portfolio. Sei Investments invested 1.41% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Sfmg Ltd Company accumulated 0.2% or 14,251 shares. Vaughan David Invs Il reported 625,728 shares stake. 117,650 were accumulated by Grassi Invest Management. Cohen Cap Inc accumulated 77,823 shares or 1.55% of the stock. Scharf Invests Limited Liability Corp invested in 6.66% or 3.43 million shares. Delta Asset Limited Com Tn reported 7.69% stake. Emerald Advisers Pa owns 0.07% invested in Microsoft Corporation (NASDAQ:MSFT) for 21,639 shares. Marathon Trading Investment Management Ltd Liability Co owns 11,873 shares or 0.03% of their US portfolio. Highlander Capital holds 8,140 shares or 0.51% of its portfolio.

Broderick Brian C, which manages about $273.95M US Long portfolio, decreased its stake in Novartis Ag Adr (NYSE:NVS) by 4,032 shares to 90,205 shares, valued at $7.57 million in 2017Q4, according to the filing. It also reduced its holding in Pfizer (NYSE:PFE) by 9,643 shares in the quarter, leaving it with 9,740 shares, and cut its stake in Unilever Plc New Adr (NYSE:UL).

Among 37 analysts covering Microsoft Corporation (NASDAQ:MSFT), 29 have Buy rating, 2 Sell and 6 Hold. Therefore 78% are positive. Microsoft Corporation had 173 analyst reports since July 22, 2015 according to SRatingsIntel. On Friday, January 27 the stock rating was maintained by RBC Capital Markets with “Outperform”. As per Friday, January 19, the company rating was maintained by UBS. The stock has “Sell” rating by Citigroup on Friday, October 27. As per Thursday, January 25, the company rating was maintained by J.P. Morgan. The firm has “Buy” rating by Cowen & Co given on Friday, July 21. On Friday, August 21 the stock rating was upgraded by Vetr to “Hold”. The rating was maintained by KeyBanc Capital Markets with “Overweight” on Thursday, February 1. The firm has “Outperform” rating by Credit Suisse given on Monday, July 17. The company was maintained on Friday, October 27 by Piper Jaffray. As per Thursday, November 10, the company rating was upgraded by Atlantic Securities.

Since February 16, 2018, it had 0 insider purchases, and 3 sales for $930,912 activity.

Among 23 analysts covering Universal Health Services Inc. (NYSE:UHS), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Universal Health Services Inc. had 63 analyst reports since August 4, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Monday, June 13 by Ladenburg Thalmann. On Wednesday, December 16 the stock rating was initiated by Credit Suisse with “Neutral”. Morgan Stanley maintained Universal Health Services, Inc. (NYSE:UHS) on Friday, March 2 with “Equal-Weight” rating. The stock of Universal Health Services, Inc. (NYSE:UHS) has “Neutral” rating given on Wednesday, January 4 by Piper Jaffray. The firm has “Buy” rating given on Sunday, August 27 by RBC Capital Markets. The stock has “Neutral” rating by Mizuho on Monday, February 27. Leerink Swann maintained it with “Outperform” rating and $132 target in Friday, September 22 report. On Friday, March 2 the stock rating was maintained by RBC Capital Markets with “Buy”. The firm has “Outperform” rating by RBC Capital Markets given on Thursday, April 27. The firm has “Neutral” rating by Mizuho given on Wednesday, November 9.

Microsoft Corporation (NASDAQ:MSFT) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>